150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonia Solvents: Dichloromethane,Tetrahydrofuran; Rt -> 10 °C; 2 H,0.5 Atm,< 10 °C; 0.5 Atm,10 °C -> 20 °C; > 6 H,20 °C 标题:Process For Preparation Of Topiramate 参考文献:China]
106881-35-0 = 97240-79-4 反应条件:1.1 Reagents: Carbon Solvents: Methanol; 30 Min,20 - 25 °C 标题:Improved Process For The Preparation Of Topiramate 参考文献:India]
20880-92-6 = 97240-79-4 反应条件:1.1 Reagents: Sulfuryl Chloride Solvents: Xylene; -20 - -5 °C1.2 Reagents: Pyridine; -20 - -5 °C; < 10 °C1.3 Reagents: Ammonia Solvents: Tetrahydrofuran; < 0 °C1.4 Solvents: Water; < 10 °C 标题:Process For The Preparation And Purification Of Topiramate 参考文献:World Intellectual Property Organization]
150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonia Solvents: Tetrahydrofuran 标题:Preparation Of Chlorosulfate And Sulfamate Derivatives Of 2,3:4,5-Bis-O-(1-Methylethylidene)-β-D-Fructopyranose And (1-Methylcyclohexyl)Methanol 参考文献:European Patent Organization]
150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonia Solvents: Tetrahydrofuran 标题:Process For The Preparation Of Chlorosulfate And Sulfamate Derivatives Of 2,3:4,5-Bis-O-(1-Methylethylidene)-β-D-Fructopyranose And (1-Methylcyclohexyl)Methanol 参考文献:United States]
106881-35-0 = 97240-79-4 反应条件:1.1 Solvents: Isopropanol; 10 Min,Rt; 15 - 20 Min; 1 H 标题:Procedure For Preparation Of Topiramate 参考文献:Slovenia]
1017969-58-2 = 97240-79-4 反应条件:1.1 Reagents: Sodium Iodide,Iron Chloride (Fecl3) Solvents: Ethyl Acetate; 25 °C 标题:Process For The Preparation Of Topiramate By Reduction Of The Azido-Sulfate With Iron(Iii) Chloride And Sodium Iodide 参考文献:India]
150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonium Carbonate,Sodium Sulfate Solvents: Acetonitrile,Tetrahydrofuran; 2 H,65 °C 标题:Synthesis Of Topiramate And Its Analogous 作者:Hu,Dandan; Fang,Zhijie; Zheng,Baohui; Li,Longxia 参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2011 卷标:42(9) 页码:645-647]
106881-35-0 = 97240-79-4 反应条件:1.1 Reagents: Hydrogen Catalysts: Nickel Solvents: Acetone; > 1 H,7.5 Kg/cm2,Rt 标题:Process For The Preparation Of Topiramate 参考文献:India]
= 97240-79-4 反应条件:1.1 Reagents: Hydrazine Solvents: Ethanol; 1 H,Rt 标题:Efficient Synthesis Of N-Oxysulfonyl Formamidines Through Thionyl Chloride-Promoted Reaction Of Sulfamates With Formamides 作者:Wusiman,Abudureheman; Hudabaierdi,Ruzeahong 参考文献:Synthetic Communications 日期:2017 卷标:47(21) 页码:2015-2021]
150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonia Solvents: Tetrahydrofuran; 5 - 7 H,20 - 30 °C 标题:Preparation Of High-Purity Topiramate For Treating Adult Epilepsy 参考文献:China]
150609-95-3 = 97240-79-4 反应条件:1.1 Reagents: Ammonium Hydroxide Solvents: Hexane,Water; 6 H,35 °C 标题:Method For Preparing Topiramate By Using Ammonia Water 参考文献:China
果糖置于吡啶,硫酸,磺酰胺体系中,用 5,5-Dimethyl-1,3-Cyclohexadiene 作为反应溶剂,化学反应生成 托吡酯 参考文献:The First General Protocol Forn-Monoalkylation Of Sulfamate Esters: Benign Synthesis Ofn-Alkyl Topiramate (Anticonvulsant Drug) Derivatives 标题:The First General Protocol Forn-Monoalkylation Of Sulfamate Esters: Benign Synthesis Ofn-Alkyl Topiramate (Anticonvulsant Drug) Derivatives 摘要:A Novel Protocol For The Highly Selective N-Monoalkylation Of The Sulfamate Ester Moiety Has Been Developed. This Reaction Proceeded Efficiently Using Alkyl Halides,Benzyl Halides And-Halo Ketones As The Electrophile In The Presence Of Kf-Al2O3 As A Cost-Effective And Robust Catalyst. This Approach Provides New Access To N-Monoalkylated Topiramate (Anticonvulsant Drug) Derivatives Which Are Potentially Of Great Importance In Medicinal Chemistry. DOI:10.1080/17415993.2015.1069294
专利号:US-10005720-B2 优先权日:2013-04-05 标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same 发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L 权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL 摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.
专利号:US-9315483-B2 优先权日:2007-09-13 标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof 发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT 权利人:CONCERT PHARMACEUTICALS INC 摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.
专利号:US-10022446-B2 优先权日:2014-08-22 标题 :PH responsive hybrid hydrogel and method of synthesis thereof 发明人:KIZILEL SEDA; CEVIK OZLEM 权利人:KOC UENIVERSITESI 摘要:A pH-responsive hybrid hydrogel, namely poly(Methacrylic acid-grafted-Ethylene Glycol) P(MAA-g-EG) cross-linked with Styrene-Butadiene-Styrene (SBS) polymer and photopolymerized by visible light. The resulting polymer turned out to have better integrities, high swelling ratios, pH-responsive and biocompatible character. Also the visible-light-induced synthesis of these pH-responsive composite wherein eosin Y is used as photoinitiator and triethanolamine is used as a co-initiator is also disclosed in the invention.
专利号:WO-2016028237-A1 优先权日:2014-08-22 标题 :A novel ph responsive hydrogel and method of synthesis 发明人:KIZILEL SEDA; CEVIK OZLEM 权利人:KOÇ ÜNIVERSITESI 摘要:A pH-responsive hydrogel, namely poly(Methacrylic acid-grafted-Ethylene Glycol) P(MAA-g-EG), that is synthesized via photopolymerization that is initiated by visible light with enhanced swelling properties as compared to P(MAA-g-EG) hydrogel that is synthesized through UV-light initiated photopolymerization technique. Also the method of synthesis of the said hydrogel and the use of the hydrogel in pharmacy for drug delivery applications.
专利号:US-2013243770-A1 优先权日:2005-10-14 标 题:Treating diabetes using inhibitors of il-1 发明人:LAU JESPER 权利人:NOVO NORDISK AS 摘要:The present invention describes a method of treating diabetes or metabolic syndrome with a compound that inhibits (a) IL-1, (b) the synthesis of IL-1, or (c) the release of IL-1.
专利号:US-9499472-B2 优先权日:2012-03-05 标题:Aspartylamide inhibitors of excitatory amino acid transporters 发明人:GERDES JOHN M; BRIDGES RICHARD J; AHMED SYED K; PATEL SARJUBHAI 权利人:THE UNIV OF MONTANA 摘要:The compounds of the invention are inhibitors of excitatory amino acid transporters (EAAT) that penetrate the blood-brain barrier to access the central nervous system. The compounds of the invention follow the structural formula: n nor a salt, ester or prodrug thereof, wherein X is a halogen, such as fluorine, or a radionuclide, such as fluorine-18. The compounds and methods described herein can be used for the treatment of, e.g., neurodegenerative disorders (e.g., amyotrophic lateral sclerosis), ischemia, spinal cord injury, and traumatic brain injury in a patient (e.g., a human). The invention further provides compounds and methods for the synthesis and use of radiographic tracers to diagnose and follow the progression of such disorders.
1: Singh M, Keer D, Klimas J, Wood E, Werb D. Topiramate for Cocaine Dependence: A Systematic Review and Meta-Analysis of Randomized Control Trials. Addiction. 2016 Jan 30. doi: 10.1111/add.13328. [Epub ahead of print] Review. doi: 10.1002/14651858.CD010008.pub2. Review. doi: 10.1111/epi.13209. Epub 2015 Oct 8. Review. doi: 10.1517/14656566.2015.1041505. Review. doi: 10.1177/1756285615578406. Review. 6: Alsaad AM, Chaudhry SA, Koren G. First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis. Reprod Toxicol. 2015 Jun;53:45-50. doi: 10.1016/j.reprotox.2015.03.003. Epub 2015 Mar 20. Review. Review. doi: 10.1097/WNO.0000000000000216. Review. doi: 10.1111/head.12480. Epub 2014 Dec 9. Review. Review. Review. doi: 10.1586/14737175.2014.958470. Epub 2014 Sep 13. Review. doi: 10.1517/14740338.2014.934669. Epub 2014 Aug 6. Review. doi: 10.1016/j.lpm.2014.02.030. Epub 2014 Jul 11. Review. French. doi: 10.1186/1471-2431-14-96. Review. 16: Xiong GL, Gadde KM. Combination phentermine/topiramate for obesity treatment in primary care: a review. Postgrad Med. 2014 Mar;126(2):110-6. doi: 10.3810/pgm.2014.03.2746. Review. doi: 10.1097/HJH.0000000000000145. Review.
合成参考文献
参考文献:10.2165/11530130-000000000-00000 摘要:Hasnain M, Vieweg WV, Fredrickson SK. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. CNS Drugs. 2010 Mar;24(3):193–206. doi: 10.2165/11530130-000000000-00000. 参考文献:10.1021/jm901855h 摘要:Joseph P, Turtaut F, Ouahrani-Bettache S, Montero JL, Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Köhler S, Winum JY, Supuran CT. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem. 2010 Mar 11;53(5):2277–85. doi: 10.1021/jm901855h. 参考文献:10.2165/11530220-000000000-00000 摘要:Michoulas A, Farrell K. Medical management of Lennox-Gastaut syndrome. CNS Drugs. 2010 May;24(5):363–74. doi: 10.2165/11530220-000000000-00000. 参考文献:10.1016/j.pediatrneurol.2009.10.001 摘要:Pandina GJ, Ness S, Polverejan E, Yuen E, Eerdekens M, Bilder RM, Ford L. Cognitive effects of topiramate in migraine patients aged 12 through 17 years. Pediatr Neurol. 2010 Mar;42(3):187–95. doi: 10.1016/j.pediatrneurol.2009.10.001. 参考文献:10.4103/0971-6866.80357 摘要:Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK, Mittal B. Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population. Indian J Hum Genet. 2011 May;17 Suppl 1():S32–40.